Atrium Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(C)(4)
RNA•Atrium Therapeutics announced inducement grants under Nasdaq Listing Rule 5635(C)(4).
1. Inducement grants
Atrium Therapeutics announced inducement grants under Nasdaq Listing Rule 5635(C)(4).
